Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of genetic hearing loss (autosomal recessive and dominant non-syndromic hearing loss), studying phenotype-genotype relationships, novel gene discovery, gene therapy for hearing loss, and the contribution
-
of team efforts is often grown out of the Centers and Institutes, including the Evelyn F. and William L. McKnight Brain Institute, the UF Genetics Institute, the Powell Gene Therapy Center, and the UF
-
. The focus of team efforts is often grown out of the Centers and Institutes, including the Evelyn F. and William L. McKnight Brain Institute, the UF Genetics Institute, the Powell Gene Therapy Center, and the
-
: This project will investigate the nuclear function of TPL-2 kinase. Techniques: Cell culture, protein-protein interaction studies, CRISPR/Cas9 gene editing, transcriptomic analysis by QPCR and RNA-seq
-
programme was established in 2007 as part of the Cluster of Excellence REBIRTH – "From Regenerative Biology to Reconstructive Therapy". The interdisciplinary programme integrates all scientific and
-
the HCC model. +++ Supervisors: Zoi Diamantopoulou and Kendle Maslowski Project summary: The circadian rhythm, an internal timekeeping system regulated by core clock genes, controls various physiological
-
of man and livestock, although due to its small genome size (9.5 Mb, <5,500 genes), it has reduced metabolic capacity [6]. Furthermore, while molecular data indicates that Perkinsela retains some key
-
Gene Therapy Professional Master’s Programs depending upon the programs’ needs and enrollment. Key Responsibilities Responsibilities include the following: review and learn key teaching points within
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 3 days ago
looking for a motivated Postdoctoral Research Associates to join our basic and translational research team in the UNC Gene Therapy Center My research is focuses on two general areas: 1) Molecular principles
-
testing of gene therapy approaches (novel haploinsufficient models of MYBPC3 hypertrophic cardiomyopathy and DSP arrhythmogenic cardiomyopathy that recapitulate the human diseases). The postdoctoral fellow